WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) ...
DexCom delivered 22% revenue growth in the third quarter. U.S. revenue grew 21% year over year, while revenue in Dexcom's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback